Ongoing Phase 3 Trials Phase 3 trials are currently underway as part of the TRIUMPH clinical trial program, enrolling thousands of participants across multiple studies examining retatrutide for obesity, type 2 diabetes, obesity-related complications, and MASH
Not randomized but prospective, rigorously adjusted, and hard to ignore
Ozempic Rebound: Why Most People Regain Weight After Stopping Semaglutide
Dosing Strategy and Clinical Implications A well-structured dosing strategy is essential for achieving predictable weight loss results
With that, its really best to talk to your doctor to see whether one or the other may be better for you
If we accept that diuretics are banned in part because they facilitate artificial weight manipulation (theyre also banned because of their ability to mask the presence of other also-banned substances), the logic for treating GLP-1 agonists differently requires some explaining